Tegretol and Gastrointestinal inflammation - a phase IV clinical study of FDA data


Gastrointestinal inflammation is reported only by a few people who take Tegretol.

The phase IV clinical study analyzes which people take Tegretol and have Gastrointestinal inflammation. It is created by eHealthMe based on reports of 40,528 people who have side effects while taking Tegretol from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.

On Jul, 02, 2022

40,528 people reported to have side effects when taking Tegretol.
Among them, 5 people (0.01%) have Gastrointestinal inflammation.

What is Tegretol?

Tegretol has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 42,338 Tegretol users for its effectiveness, alternative drugs and more.

What is Gastrointestinal inflammation?

Gastrointestinal inflammation (inflammation of stomach and intestine) is found to be associated with 761 drugs and 492 conditions by eHealthMe.

Number of Tegretol and Gastrointestinal inflammation reports submitted per year:

Could Tegretol cause Gastrointestinal inflammation?

Time on Tegretol when people have Gastrointestinal inflammation *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Gastrointestinal inflammation when taking Tegretol *:

  • female: 40 %
  • male: 60 %

Age of people who have Gastrointestinal inflammation when taking Tegretol *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 50 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 50 %

Common drugs people take besides Tegretol *:

  1. Methotrexate: 2 people, 40.00%
  2. Humira: 2 people, 40.00%
  3. Viread: 1 person, 20.00%
  4. Tylenol: 1 person, 20.00%
  5. Remodulin: 1 person, 20.00%
  6. Lamictal: 1 person, 20.00%
  7. Klonopin: 1 person, 20.00%
  8. Kaletra: 1 person, 20.00%
  9. Folic Acid: 1 person, 20.00%
  10. Emtriva: 1 person, 20.00%

Common side effects people have besides Gastrointestinal inflammation *:

  1. Flatulence (flatus expelled through the anus): 2 people, 40.00%
  2. Wound Complication: 1 person, 20.00%
  3. White Blood Cell Count Decreased: 1 person, 20.00%
  4. Gallstones (stone formation by bile component): 1 person, 20.00%
  5. Enteritis (inflammation of the small intestine): 1 person, 20.00%
  6. Diarrhea: 1 person, 20.00%
  7. Death: 1 person, 20.00%
  8. Cytolytic Hepatitis (dissolution or destruction of a liver cell): 1 person, 20.00%
  9. Cutaneous Vasculitis (an inflammatory process affecting the vessel wall that leads to its damage): 1 person, 20.00%
  10. Cholecystitis (infection of gallbladder): 1 person, 20.00%

Common conditions people have *:

  1. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 20.00%
  2. Pain: 1 person, 20.00%
  3. Hiv Infection: 1 person, 20.00%
  4. Emotional Disorder: 1 person, 20.00%
  5. Diabetes: 1 person, 20.00%
  6. Depression: 1 person, 20.00%
  7. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 1 person, 20.00%
  8. Bipolar Disorder (mood disorder): 1 person, 20.00%
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tegretol and have Gastrointestinal inflammation?

Check whether Gastrointestinal inflammation is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of Tegretol:

Gastrointestinal inflammation treatments and more:

COVID vaccines that are related to Gastrointestinal inflammation:

How severe was Gastrointestinal inflammation and when was it recovered:

Expand to all the drugs that have ingredients of carbamazepine:

Common drugs associated with Gastrointestinal inflammation:

All the drugs that are associated with Gastrointestinal inflammation:

Common conditions associated with Gastrointestinal inflammation:

All the conditions that are associated with Gastrointestinal inflammation:

How the study uses the data?

The study uses data from the FDA. It is based on carbamazepine (the active ingredients of Tegretol) and Tegretol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: